FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012194181> ?p ?o ?g. }

• W2012194181 endingPage "1044" @default.
• W2012194181 startingPage "1037" @default.
• W2012194181 abstract "Insulin analogues are used in the treatment of diabetes to mimic physiological insulin secretion. Glargine is used to provide basal insulin levels. Previous work has shown no differences in glucose uptake when glargine was compared to native insulin. The action of insulin on protein and lipid metabolism is studied infrequently, but these important actions should be considered with insulin analogues. In HepG2 cells, protein degradation was inhibited significantly less by glargine (15% over 3 hours) than by insulin (∼20% over 3 hours) (P < .05). Lipid metabolism was investigated in 3T3-L1 cells. In these cells glucose oxidation to CO2 was effected equally, but glargine was less potent than insulin at inhibiting epinephrine-stimulated lipolysis (EC50 = 1.4 v 0.35 nmol/L, P < .001) and at stimulating lipogenesis (EC50 = 1.27 v 8.06 nmol/L, P < .01). Since the action of insulin on protein and lipid metabolism has been suggested to be due to the metabolism of the hormone, we compared the cellular handling of 125I[A14]-glargine to 125I[A14]-insulin in HepG2 cells. While binding of glargine to the insulin receptor was identical to insulin, degradation of glargine was reduced compared to insulin (16.3% ± 0.3% v 21.6% ± 0.4% degraded/h, P < .01). Less degraded glargine than insulin was released from cells previously loaded with radiolabeled material (50.1% ± 2.4% v 58.3% ± 1.4%/2 h, P < .02). The amount of intact glargine released was concomitantly increased compared to insulin (44.8% ± 2.6% v 35.8% ± 1.4%/2 h, P < .02). These data provide further evidence for a relationship between insulin metabolism and insulin action on protein and lipid metabolism; however, the clinical relevance of these differences is hard to realize, since for the most part glargine, used as a basal insulin, is administered in addition to other shorter-acting insulin or analogues, and their effects will mask or reduce glargine effects on lipolysis and protein degradation. However, these studies do show that properties of insulin other than glucose metabolism and mitogenesis must be considered when studying insulin analogues." @default.
• W2012194181 created "2016-06-24" @default.
• W2012194181 creator A5042270742 @default.
• W2012194181 creator A5046360192 @default.
• W2012194181 creator A5052832946 @default.
• W2012194181 creator A5060165271 @default.
• W2012194181 date "2004-08-01" @default.
• W2012194181 modified "2023-10-01" @default.
• W2012194181 title "Reduced action of insulin glargine on protein and lipid metabolism: Possible relationship to cellular hormone metabolism" @default.
• W2012194181 cites W1531995193 @default.
• W2012194181 cites W1631575592 @default.
• W2012194181 cites W1862633417 @default.
• W2012194181 cites W1969330529 @default.
• W2012194181 cites W1987346827 @default.
• W2012194181 cites W1994020371 @default.
• W2012194181 cites W1997676993 @default.
• W2012194181 cites W1998801606 @default.
• W2012194181 cites W1999331804 @default.
• W2012194181 cites W2002070144 @default.
• W2012194181 cites W2014733700 @default.
• W2012194181 cites W2018362483 @default.
• W2012194181 cites W2018742307 @default.
• W2012194181 cites W2027846671 @default.
• W2012194181 cites W2042436886 @default.
• W2012194181 cites W2054875148 @default.
• W2012194181 cites W2061317503 @default.
• W2012194181 cites W2089042218 @default.
• W2012194181 cites W2092964123 @default.
• W2012194181 cites W2107372727 @default.
• W2012194181 cites W2119954342 @default.
• W2012194181 cites W2122613061 @default.
• W2012194181 cites W2132844317 @default.
• W2012194181 cites W2136220429 @default.
• W2012194181 cites W2144080769 @default.
• W2012194181 cites W2198817635 @default.
• W2012194181 cites W3192431217 @default.
• W2012194181 cites W4230263400 @default.
• W2012194181 cites W4231163287 @default.
• W2012194181 cites W4236824344 @default.
• W2012194181 cites W4242696681 @default.
• W2012194181 cites W4253916027 @default.
• W2012194181 doi "https://doi.org/10.1016/j.metabol.2004.02.013" @default.
• W2012194181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15281015" @default.
• W2012194181 hasPublicationYear "2004" @default.
• W2012194181 type Work @default.
• W2012194181 sameAs 2012194181 @default.
• W2012194181 citedByCount "13" @default.
• W2012194181 countsByYear W20121941812012 @default.
• W2012194181 countsByYear W20121941812014 @default.
• W2012194181 countsByYear W20121941812022 @default.
• W2012194181 crossrefType "journal-article" @default.
• W2012194181 hasAuthorship W2012194181A5042270742 @default.
• W2012194181 hasAuthorship W2012194181A5046360192 @default.
• W2012194181 hasAuthorship W2012194181A5052832946 @default.
• W2012194181 hasAuthorship W2012194181A5060165271 @default.
• W2012194181 hasConcept C126322002 @default.
• W2012194181 hasConcept C134018914 @default.
• W2012194181 hasConcept C140985366 @default.
• W2012194181 hasConcept C141359234 @default.
• W2012194181 hasConcept C171089720 @default.
• W2012194181 hasConcept C185592680 @default.
• W2012194181 hasConcept C2779306644 @default.
• W2012194181 hasConcept C2779920387 @default.
• W2012194181 hasConcept C2780668416 @default.
• W2012194181 hasConcept C4733338 @default.
• W2012194181 hasConcept C62231903 @default.
• W2012194181 hasConcept C71924100 @default.
• W2012194181 hasConceptScore W2012194181C126322002 @default.
• W2012194181 hasConceptScore W2012194181C134018914 @default.
• W2012194181 hasConceptScore W2012194181C140985366 @default.
• W2012194181 hasConceptScore W2012194181C141359234 @default.
• W2012194181 hasConceptScore W2012194181C171089720 @default.
• W2012194181 hasConceptScore W2012194181C185592680 @default.
• W2012194181 hasConceptScore W2012194181C2779306644 @default.
• W2012194181 hasConceptScore W2012194181C2779920387 @default.
• W2012194181 hasConceptScore W2012194181C2780668416 @default.
• W2012194181 hasConceptScore W2012194181C4733338 @default.
• W2012194181 hasConceptScore W2012194181C62231903 @default.
• W2012194181 hasConceptScore W2012194181C71924100 @default.
• W2012194181 hasIssue "8" @default.
• W2012194181 hasLocation W20121941811 @default.
• W2012194181 hasLocation W20121941812 @default.
• W2012194181 hasOpenAccess W2012194181 @default.
• W2012194181 hasPrimaryLocation W20121941811 @default.
• W2012194181 hasRelatedWork W1592691368 @default.
• W2012194181 hasRelatedWork W2003137510 @default.
• W2012194181 hasRelatedWork W2046548573 @default.
• W2012194181 hasRelatedWork W2055916516 @default.
• W2012194181 hasRelatedWork W2115316230 @default.
• W2012194181 hasRelatedWork W2130981205 @default.
• W2012194181 hasRelatedWork W2144650717 @default.
• W2012194181 hasRelatedWork W2153868682 @default.
• W2012194181 hasRelatedWork W2155030806 @default.
• W2012194181 hasRelatedWork W2161931749 @default.
• W2012194181 hasVolume "53" @default.
• W2012194181 isParatext "false" @default.
• W2012194181 isRetracted "false" @default.
• W2012194181 magId "2012194181" @default.

• next